Researchers test if generic schizophrenia drug works like brand name
NCT ID NCT07266792
First seen Jan 04, 2026 · Last updated Apr 22, 2026 · Updated 16 times
Summary
This study tested whether a new version of the schizophrenia medication brexpiprazole gets into the bloodstream the same way as the already-approved version. It involved 36 healthy adults who took single doses of each drug. The goal was to see if the two versions are bioequivalent, meaning they deliver the same amount of medicine to the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliantha Research Limited
Ahmedabad, Gujarat, 382210, India
Conditions
Explore the condition pages connected to this study.